
Center for Cancer Epigenetics
Xiaodong Cheng, Ph.D., and Mark Bedford, Ph.D.
Co-Directors
- Departments, Labs and Institutes
- Research Centers and Programs
- Center for Cancer Epigenetics
The Center for Cancer Epigenetics (CCE), is most recently co-directed by Xiaodong Cheng, Ph.D., and Mark Bedford, Ph.D., professors in Epigenetics and Molecular Carcinogenesis. The CCE was designed to bring together faculty members throughout the Texas Medical Center with research programs focused on epigenetics, which is the study of heritable and acquired changes that affect gene expression and cellular differentiation without DNA sequence alteration.
What is Epigenetics? Epigenetic changes are thought to be just as important as gene mutations in cancer development. The ultimate goal of the center has been to define the full spectrum of epigenetic changes that occur in cancers, to discover the molecular causes of these changes and to translate that newly gained knowledge into the clinic in the form of novel, epigenetic-based therapies.
Faculty and Staff
Members of the center have included faculty from several basic research and clinical departments at MD Anderson, Baylor College of Medicine and other Texas Medical Center institutions.
Events
Information and ideas have traditionally been exchanged during bi-weekly seminars and a monthly Distinguished Lecturer Series.
Contact Us
Xiaodong Cheng, Ph.D.
Department of Epigenetics and Molecular Carcinogenesis
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: Unit 1000
Houston, TX 77030
xcheng5@mdanderson.org
Mark T. Bedford, Ph.D.
Department of Epigenetics and Molecular Carcinogenesis
The University of Texas MD Anderson Cancer Center
1881 East Rd
Unit Number: Unit 1951
Houston, TX 77054
mtbedford@mdanderson.org